AKT1 and breast cancer: Elucidating the role of API in the PI3K/AKT/p53 pathway provides a scientific foundation for future preclinical and clinical investigations intended to harness this natural compound for the targeted elimination of BCSCs and to improve patient outcomes in breast cancer treatment.